Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7315
-0.0166 (-2.22%)
At close: Feb 11, 2026, 4:00 PM EST
0.7370
+0.0055 (0.75%)
After-hours: Feb 11, 2026, 4:00 PM EST
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $16.89 million as of February 11, 2026. Its market cap has increased by 429.27% in one year.
Market Cap
16.89M
Enterprise Value
13.15M
1-Year Change
429.27%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $16.89M, a decrease of -74.13%. That is a compound annual growth rate of -26.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 17.27M | -42.01% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 18.81M |
| VYNE Therapeutics | 18.64M |
| Citius Pharmaceuticals | 18.55M |
| FibroBiologics | 17.06M |
| Klotho Neurosciences | 16.96M |
| CASI Pharmaceuticals | 16.85M |
| Liminatus Pharma | 16.16M |
| Lexaria Bioscience | 16.04M |